Brief: Nykode Therapeutics Mulls Private Placement
BRIEF-Nykode Therapeutics Mulls Private Placement Aug 27 (Reuters) - Nykode Therapeutics ASA NYKD.OL:
CONTEMPLATED PRIVATE PLACEMENT
CONTEMPLATED PRIVATE PLACEMENT OF UP TO 65 MILLION NEW SHARES IN COMPANY, EQUIVALENT OF ABOUT 20% OF OUTSTANDING SHARES
NET PROCEEDS FROM PRIVATE PLACEMENT ALONG WITH EXISTING CASH WILL SUSTAIN RUNWAY WELL INTO 2029,
Source text: https://mfn.se/ob/a/nykode-therapeutics/nykode-therapeutics-asa-contemplated-private-placement-31945dc4
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026